Vaccines Market Size, Share & Analysis | Industry Report 2024

The global vaccines market was valued at $32 bn in 2016 and is anticipated to reach $61.6 bn by 2024.

The vaccines market is expected to grow owing to factors such as rise in prevalence of chronic diseases, growing healthcare expenditure, improvement in access to healthcare, high investment in R&D, increasing support from government and stakeholders such as UNICEF, WHO (World Health Organization), PAHO (Pan-American Healthcare Organisation) and others. The rise in prevalence of tuberculosis, influenza, rotavirus infection, polio, measles and other diseases is a major concern for governments across the developed and emerging nations.

The increasing healthcare expenditure to support the treatment of millions of patients suffering from various diseases is a key challenge for the healthcare providers, payers, and governments. In 2014, the Ebola outbreak in western Africa was declared as a Public Health Emergency of International Concern under the WHO International Health Regulations (2005). As per estimates by WHO, the number of Ebola cases reported in Sierra Leone were 14,124, Guinea-3,811 cases, Liberia-10,675 cases.

To resolve the crisis and prevent future disasters, nearly 2 million doses of three candidate vaccines were manufactured by companies such as GlaxoSmithKline, Johnson & Johnson, and Merck. It is estimated that more than 20,000 people were vaccinated in 2014-15. Furthermore, GAVI Vaccine Alliance and Merck Sharp & Dohme Corporation have entered into a USD 5 million advance purchase agreement to support the development of Ebola vaccine stockpile. These drugs have not received the U.S. FDA, and EMEA approval, and are presently procured by countries to conduct clinical studies and treat the affected patients.

North America accounted for the maximum share, followed by Europe and Asia Pacific. The global vaccines market is dominated by the high-income countries due to their high healthcare expenditure on healthcare infrastructure, community development, research & development, and vaccination programs for different diseases. As per WHO estimates, the high-income countries in North America and Europe account for nearly 82% of the global vaccine sales by revenue and 20% by volume. These regions spend significantly on manufacturing and importing the most advanced vaccines and pay a higher premium for the products compared to other regions. In North America, U.S. dominates the regional market due to a high incidence rate of diseases, high focus on research & development and constant efforts by the government to provide the best healthcare services to its citizens.

Asia Pacific is expected to emerge as the fastest growing region due to increasing government efforts in providing vaccination to its citizens. The high prevalence of various diseases in the region is driving the increase in healthcare expenditure and improvement in access to basic healthcare facilities. The governments in coordination with agencies such as WHO, UNICEF are actively working toward eliminating the threat of infectious diseases by conducting extensive vaccination programs.

Click the link below to view the report description:
www.ameriresearch.com/product/vaccines-market-size/

Key findings from the study: -
• As per estimates by WHO, the number of Ebola cases reported in Sierra Leone were 14,124, Guinea-3,811 cases, Liberia-10,675 cases. To resolve the crisis and prevent future disasters, nearly 2 million doses of three candidate vaccines were manufactured by companies such as GlaxoSmithKline, Johnson & Johnson, and Merck.

• The pricing power is skewed toward large purchase organizations such as UNICEF and PAHO, which negotiate and procure vaccines for supplying in more than 100 countries.

• Key players operating in the market include GlaxoSmithKline, plc., Novartis AG, Emergent BioSolutions, Inc., Sanofi Pasteur, Inc., AstraZeneca Plc, Takeda Pharmaceuticals Company Ltd., Valeant Pharmaceuticals International, Inc., Astellas Pharma Inc. and others

Ameri Research has segmented the Vaccines Market by product type, Type and end-use.

Market Segmentation:

Vaccines Market by Product (Revenue, Million, 2014 – 2024)
• Live Attenuated Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Conjugate Vaccines
• DNA Vaccines

Vaccines Market by Disease Type, Revenue, USD Million, 2014 – 2024)
• North America
o U.S.
o Canada

• Europe
o UK
o Germany
o France
o Italy
o Spain

• Asia Pacific
o Japan
o China
o India
o Australia

• Latin America
o Brazil
o Mexico
o Columbia

• Middle East and Africa
o South Africa
o Saudi Arabia

Browse Full Report @ www.ameriresearch.com/product/vaccines-market-size/

About Us:

Ameri Research Inc. (www.ameriresearch.com) is a U.S. based market research and consulting company, registered in the State of Florida and headquartered in Tampa Bay Area. At Ameri Research we are passionately curious about people, markets, brands and society. Our ability to gauge market movements, deep expertise in data science, strong domain expertise and years of collective global experiences helps us to bring unmatched quality in deliverables to our clients. With carefully planned systems and processes in place, we cater to the requirements of our clients in a timely and cost-efficient manner, bringing increased predictability to their business. Each year we are publishing more than 100 syndicated reports in healthcare, chemicals, materials, food & beverages, defense & aerospace, media & entertainment, sports & fitness, and energy. We offer our clients a unique depth of knowledge and expertise around-

Market Mapping
Opportunity Assessment
Positioning
Pricing Analysis
Market Entry Strategy
Competitive Intelligence
Program Evaluation
Performance Reporting
Data Analytics
Developing a culture of collaboration and curiosity, we attract the highest caliber of likeminded people having ability to influence and shape the future.

Follow us on LinkedIn for our latest upcoming reports www.linkedin.com/company/ameri-research-inc./
Follow us on Facebook for our latest upcoming reports www.facebook.com/AmeriResearchInc/
Follow us on Twitter for our latest upcoming reports www.twitter.com/AmeriResearch

Contact Us:

Ameri Research Inc.
6816 Muncaster Ct,
Tampa, FL 33625
United States.
Tel: 1-813-666-0858
Email: Inquiry@ameriresearch.com
Web: www.ameriresearch.com

This release was published on openPR.